296 related articles for article (PubMed ID: 9252071)
1. Significance of IgM anti-HCV core level in chronic hepatitis C.
Papatheodoridis GV; Delladetsima JK; Katsoulidou A; Sypsa V; Albrecht M; Michel G; Hatzakis A; Tassopoulos NC
J Hepatol; 1997 Jul; 27(1):36-41. PubMed ID: 9252071
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.
Martinelli AL; Brown D; Braun HB; Michel G; Dusheiko GM
J Hepatol; 1996 Jan; 24(1):21-6. PubMed ID: 8834020
[TBL] [Abstract][Full Text] [Related]
3. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
[TBL] [Abstract][Full Text] [Related]
4. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.
Bizollon T; Ahmed SN; Guichard S; Chevallier P; Adham M; Ducerf C; Baulieux J; Trepo C
Gut; 2000 Nov; 47(5):698-702. PubMed ID: 11034588
[TBL] [Abstract][Full Text] [Related]
5. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
[TBL] [Abstract][Full Text] [Related]
6. IgM antibody response to the hepatitis C virus core protein in intravenous drug users.
Toniutto P; Falleti E; Gasparini V; Fabris C; Tisminetzky SG; Lombardelli T; Pacco P; Satta A; Pirisi M
Diagn Microbiol Infect Dis; 1999 Feb; 33(2):69-73. PubMed ID: 10091028
[TBL] [Abstract][Full Text] [Related]
7. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
[TBL] [Abstract][Full Text] [Related]
10. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon.
Negro F; Abate ML; Mondardini A; Baldi M; Leandro G; Lombardi S; Wolfe L; Ryff JC; Verme G; Brunetto MR
J Viral Hepat; 1995; 2(4):171-4. PubMed ID: 7489343
[TBL] [Abstract][Full Text] [Related]
11. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
Tran A; Yang G; Dreyfus G; Rouquié P; Durant J; Rampal A; Rampal P; Benzaken S
Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
[TBL] [Abstract][Full Text] [Related]
12. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G and M hepatitis C virus core antibody (JCC.2) response in chimpanzees infected experimentally with hepatitis C virus.
Shioda A; Moriyama M; Hayashi N; Sugitani M; Uchida T; Shikata T; Nishizono A; Abe K; Arakawa Y
Intervirology; 2000; 43(3):146-53. PubMed ID: 11044808
[TBL] [Abstract][Full Text] [Related]
14. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
Nagayama R; Miyake K; Tsuda F; Okamoto H
J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
[TBL] [Abstract][Full Text] [Related]
15. [Antibodies to different virus antigens in patients with chronic hepatitis C].
Krasavtsev EL; Zhavoronok SV; Mitsura VM; Demchilo AP
Zh Mikrobiol Epidemiol Immunobiol; 2006; (2):57-61. PubMed ID: 16758901
[TBL] [Abstract][Full Text] [Related]
16. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
Ansari MA; Irshad M; Agarwal SK; Chosdol K
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
[TBL] [Abstract][Full Text] [Related]
17. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
Yuki N; Hayashi N; Ohkawa K; Hagiwara H; Oshita M; Katayama K; Sasaki Y; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1995 Aug; 22(2):402-6. PubMed ID: 7543432
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin M and A antibodies to hepatitis C core antigen in chronic hepatitis C virus infection.
Lau GK; Lesniewski R; Johnson RG; Davis GL; Lau JY
J Med Virol; 1994 Sep; 44(1):1-4. PubMed ID: 7528259
[TBL] [Abstract][Full Text] [Related]
19. Lack of monomeric IgM anti-hepatitis C virus (HCV) core antibodies in patients with chronic HCV infection.
Negro F; Troonen H; Michel G; Giostra E; Albrecht M; Perrin L; Hadengue A
J Virol Methods; 1996 Jul; 60(2):179-82. PubMed ID: 8844624
[TBL] [Abstract][Full Text] [Related]
20. Is the detection of anti-hepatitis C virus core IgM influenced by the presence of serum rheumatoid factor?
Pawlotsky JM; Remire J; Darthuy F; Intrator L; Udin L; Dhumeaux D; Duval J
J Med Virol; 1995 Jan; 45(1):68-70. PubMed ID: 7536232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
